Filing Details
- Accession Number:
- 0001213900-23-098312
- Form Type:
- 13G Filing
- Publication Date:
- 2023-12-21 19:00:00
- Filed By:
- Lim Seah H.
- Company:
- Emmaus Life Sciences Inc. (OTCMKTS:EMMA)
- Filing Date:
- 2023-12-22
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Seah H. Lim, M.D., Ph.D | 4,586,626 | 4,586,626 | 4,586,626 | 7.4% |
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. )*
EMMAUS LIFE SCIENCES, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.001 PER SHARE
(Title of Class of Securities)
29137T101
(CUSIP Number)
December 18, 2023
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☒ Rule 13d-1(c)
☐ Rule 13d-1(d)
| * | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
SCHEDULE 13G
| CUSIP NO. 29137T101 | Page 2 of 5 Pages |
| 1 | NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Seah H. Lim, M.D., Ph.D. | |
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* | (a) ☐ (b) ☐ |
| 3 | SEC USE ONLY
| |
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
USA | |
NUMBER
OF | 5 | SOLE VOTING POWER
| |
| 4,586,626 | |||
| 6 | SHARED VOTING POWER
| ||
| None | |||
| 7 | SOLE DISPOSITIVE POWER
| ||
| 4,586,626 | |||
| 8 | SHARED DISPOSITIVE POWER None |
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
| |
| 4,586,626 | ||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* | ☐
|
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
| |
| 7.4% | ||
| 12 | TYPE OF REPORTING PERSON*
| |
| IN | ||
| CUSIP NO. 29137T101 | Page 3 of 5 Pages |
| Item 1(a). | Name of Issuer |
Emmaus Life Sciences, Inc.
| Item 1(b). | Address of Issuer’s Principal Executive Offices |
21250 Hawthorne Boulevard, Suite 800
Torrance, California 90503
| Item 2(a). | Name of Person Filing |
Seah H. Lim, M.D., Ph.D.
| Item 2(b). | ADDRESS OF PRINCIPAL BUSINESS OFFICE |
21250 Hawthorne Boulevard, Suite 800
Torrance, California 90503
| Item 2(c). | Citizenship |
A U.S. citizen and resident of New York
| Item 2(d). | Title of Class of Securities |
Common stock, par value $0.001 per share
| Item 2(e). | CUSIP NUMBER |
29137T101
| Item 3. | STATEMENTS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) |
Not applicable.
| Item 4. | Ownership |
See Rows 5 through 11 of cover pages.
| Item 5. | OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial holder of more than five percent of the class of securities, check the following. ☐
| CUSIP NO. 29137T101 | Page 4 of 5 Pages |
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person |
Not applicable.
| Item 7. | IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON |
Not applicable.
| Item 8. | Identification and Classification of Members of the Group |
Not applicable.
| Item 9. | Notice of Dissolution of Group |
Not applicable.
| Item 10. | Certification |
By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
| CUSIP NO. 29137T101 | Page 5 of 5 Pages |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| Date: December 22, 2023 | |
| /s/ Seah H. Lim, M.D., Ph.D. | |
| Seah H. Lim, M.D., Ph.D. |